Where does Uppthera rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Uppthera ranks #43,860 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Uppthera hold?

Uppthera holds 6 US utility patents granted between 2021 and 2025, spanning 5 technology areas.

What is Uppthera's Innovation Score?

Uppthera has an Innovation Score of 39.1 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Uppthera focus on?

Uppthera's top technology area is C07D (Heterocyclic Compounds) with 5 patents, ranking #1,402 of 3,165 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Uppthera's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Uppthera.

What does claim depth mean for Uppthera's patents?

Uppthera's patents average 7.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Uppthera patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Uppthera

USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Uppthera ranks #43,860 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.

#43,860
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.1/100): 7.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R43860 · Foreign Corporation #43,860 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #43,860/49,997
PHOTO-FINISH UNIVERSITÉ DES…
CPC-NARROW C07D · 5 areas
INNOV-THIN 39.1/100
CLAIMS-SPARSE 7.5 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: UNIVERSITÉ DES Antilles ET DE LA Guyane (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Uppthera’s 39.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (17%) Velocity 20.0 pts (51%) Breadth 7.9 pts (20%) Claim depth 4.5 pts (12%)

Qualcomm Incorporated · highest

85
China Communication… · near

39
Monterey Research · near

39
Primetals USA · near

39
The Southern · near

39
Uppthera · this assignee

39
3D Lighting… · lowest

7

What this shows Uppthera's Innovation Score is 39.1/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Uppthera?

Each dot is one of Uppthera’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Uppthera’s own 7.5 claims/patent is at or below the 12.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Uppthera vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Uppthera's grants concentrate

Uppthera is a focused PatentsView assignee: 5 CPC subclasses with 83.3% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2021. By volume, Uppthera sits between University OF Huddersfield and Ureka Sarl.

Uppthera's three-year grant acceleration

Uppthera shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

University OF Hud…

6
UniversitÉ DES An…

6
Upaid Systems

6
UPL Europe

6
Urakami

6
Urban SKY

6
URC Ventures

6
Ureka Sarl

6
Uppthera ◀

6

What this shows Uppthera holds 6 patents at rank #43,802, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Uppthera

By rank, the assignees closest to #43,802 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Uppthera's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Uppthera, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Uppthera ranks #1,402 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

The Southern Company 39 Primetals Technologies USA LLC 39 China Communication Technology Co., Ltd. 39 Monterey Research, LLC 39

Uppthera's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Uppthera patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	16.7%
2022	1	16.7%
2023	1	16.7%
2024	2	33.3%
2025partial year	1	16.7%

Which technologies does Uppthera patent most?

C07D - Heterocyclic Compounds 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C07K - Peptides 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Uppthera's patent record in context - here's where to go next.

Uppthera's lead technology class is C07D (Heterocyclic Compounds), 83.3% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #43,860 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Uppthera against University OF Huddersfield, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.